Invesco Ltd. Has $691.53 Million Holdings in Encompass Health Corporation $EHC

Invesco Ltd. decreased its stake in shares of Encompass Health Corporation (NYSE:EHC) by 3.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,639,124 shares of the company’s stock after selling 179,659 shares during the quarter. Invesco Ltd. owned about 5.60% of Encompass Health worth $691,526,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of EHC. WPG Advisers LLC bought a new stake in Encompass Health in the first quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the period. Employees Retirement System of Texas bought a new position in Encompass Health in the second quarter worth approximately $57,000. Parkside Financial Bank & Trust grew its stake in Encompass Health by 179.5% in the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after acquiring an additional 307 shares during the period. Finally, Park Place Capital Corp acquired a new position in shares of Encompass Health during the second quarter worth approximately $72,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Performance

EHC stock opened at $113.02 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The firm has a market cap of $11.37 billion, a PE ratio of 21.36, a P/E/G ratio of 2.02 and a beta of 0.73. The business has a 50 day moving average of $119.72 and a 200-day moving average of $119.38. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on EHC shares. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. UBS Group lifted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, November 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.